Related Experiment Video
Updated: Jul 29, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid
A Hashiramoto1, H Sano, T Maekawa
1Kyoto Prefectural University of Medicine, Japan.
Objective:
To investigate the role of c-myc in the pathogenesis of rheumatoid arthritis (RA) and the mechanism of synovial apoptosis.
Methods:
Using cultured human synoviocytes from patients with RA and c-myc antisense oligodeoxynucleotides (AS ODN), we examined the inhibition of cell proliferation by the MTT assay and the induction of apoptosis with TUNEL staining and fluorescence microscopy. In addition, the effect of c-myc on down-regulation of Fas expression was analyzed by flow cytometry, cytotoxicity assay, and reverse transcriptase-polymerase chain reaction.
Results:
Treatment with c-myc AS ODN induced inhibition of cell proliferation, along with down-regulation of c-Myc protein and c-myc messenger RNA (mRNA) expression. The morphologic changes of synovial cell death were typical of apoptosis. In addition, c-myc AS ODN treatment down-regulated expression of Fas mRNA but not Fas antigen. Analysis of the involvement of the caspase cascade revealed that the cytotoxic activity of c-myc AS ODN was completely blocked by inhibitors of both caspase 1 (YVAD-FMK) and caspase 3 (DEVD-FMK).
Conclusion:
Our results strongly suggest that c-myc AS ODN might be a useful therapeutic tool in RA and clarify that cell death by c-myc AS ODN is induced through the caspase cascade, similar to Fas-induced apoptosis. In addition, combination therapy with anti-Fas antibody and c-myc AS ODN reduced Fas-dependent cytotoxicity.
Insights
C-myc antisense oligodeoxynucleotides (AS ODN) inhibit rheumatoid arthritis (RA) cell proliferation and induce apoptosis via the caspase cascade. This suggests c-myc AS ODN may be a potential therapeutic for RA.
Area of Science:
- Molecular Biology
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) pathogenesis involves synovial inflammation and apoptosis.
- The role of the c-myc oncogene in RA and its impact on synovial apoptosis requires further investigation.
Purpose of the Study:
- To elucidate the role of c-myc in rheumatoid arthritis (RA) pathogenesis.
- To investigate the mechanism of synovial apoptosis induced by c-myc modulation.
Main Methods:
- Utilized cultured human synoviocytes from RA patients.
- Employed c-myc antisense oligodeoxynucleotides (AS ODN) to inhibit c-myc expression.
- Assessed cell proliferation (MTT assay), apoptosis (TUNEL staining), Fas expression (flow cytometry, RT-PCR), and caspase cascade involvement (inhibitor assays).
Main Results:
- c-myc AS ODN treatment inhibited synoviocyte proliferation and down-regulated c-Myc protein and mRNA.
- Morphological analysis confirmed apoptosis induction.
- c-myc AS ODN treatment reduced Fas mRNA but not Fas antigen expression.
- Caspase 1 and caspase 3 inhibitors blocked the cytotoxic effects of c-myc AS ODN.
Conclusions:
- c-myc AS ODN demonstrates potential as a therapeutic agent for RA.
- Cell death induced by c-myc AS ODN occurs through the caspase cascade, akin to Fas-induced apoptosis.
- Combination therapy with anti-Fas antibody and c-myc AS ODN enhanced the reduction of Fas-dependent cytotoxicity.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway

